XGN
(NASDAQ)Exagen Inc.
$7.92-- (--)
Loading... - Market loading
Exagen (XGN) Stock Price & Financial Analysis
Exagen Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$6.56 - $6.86
52-Week High$12.23
52-Week Low$2.59
Open$6.62
Volume739.37K
Average Volume (3M)384.35K
Market Cap159.83M
Shares Outstanding23.85M
Price to Sales (P/S)2.34
Price to Book (P/B)11.07
EV/EBITDA-13.35
Revenue (TTM)68.38M
Net Income (TTM)-20.17M
Free Cash Flow (TTM)-14.13M
EPS (TTM)$-0.90
Profit Margin-29.49%
Operating Margin-20.65%
Return on Equity (ROE)-139.73%
Debt to Equity1.76
50-Day MA$4.93
200-Day MA$4.97
52-Week Change-29.40%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$6.56 - $6.86
52-Week High$12.23
52-Week Low$2.59
Open$6.62
Volume739.37K
Average Volume (3M)384.35K
Market Cap159.83M
Shares Outstanding23.85M
Price to Sales (P/S)2.34
Price to Book (P/B)11.07
EV/EBITDA-13.35
Revenue (TTM)68.38M
Net Income (TTM)-20.17M
Free Cash Flow (TTM)-14.13M
EPS (TTM)$-0.90
Profit Margin-29.49%
Operating Margin-20.65%
Return on Equity (ROE)-139.73%
Debt to Equity1.76
50-Day MA$4.93
200-Day MA$4.97
52-Week Change-29.40%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Exagen
What is the current stock price for XGN?
As of the latest trading session, XGN stock trades at $6.70. The 52-week range is $2.59–$12.23, with a day range of $6.56–$6.86.
What is the P/E ratio for XGN?
The P/E ratio (Price-to-Earnings) for XGN is shown in the Key Statistics section. This valuation metric helps compare Exagen Inc. to industry peers.
Does XGN pay dividends?
Exagen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for XGN?
Based on 1 analyst, the consensus for XGN is Buy.
What is the market cap of XGN?
Exagen's market capitalization is $159.8M, classifying it as a micro-cap company. Exagen operates in the Healthcare sector within the Diagnostics & Research industry.